首页 工具
登录
购物车

搜索结果

Search Results for " syk "

67

抑制剂 & 化合物

5

天然产物

如果没找到您满意的产品或者您对产品有其他要求,可以联系我们专业顾问为您提供针对性的合理建议。     QQ咨询       网站留言咨询

提交您的定制咨询

点击图片重新获取验证码
Cat. No. Product Name Target Signaling Pathways
T4391 Syk Inhibitor II dihydrochloride

Syk Inhibitor II (hydrochloride)

Others; Tyrosine Kinases; Syk; PKC; BTK Angiogenesis; Chromatin/Epigenetic; Cytoskeletal Signaling; Others; Tyrosine Kinase/Adaptors
Syk Inhibitor II (hydrochloride) 是一种非受体酪氨酸激酶,磷酸化后,它与 FcRγ 链的基于免疫受体酪氨酸的激活基序结合,并介导与血小板功能和炎症相关的下游信号传导。 Syk inhibitor II 是一种可渗透细胞的嘧啶-甲酰胺化合物,以 ATP 竞争性方式选择性和可逆地阻断 Syk (IC50 = 41 nM)。它对 PKCε、PKCβII、ZAP-70、Btk 和 Itk 的效力要低得多(IC50s 分别为5.1、11、11.2、15.5 和 22.6 μM)。
T13045 Syk-IN-3

Syk Angiogenesis; Tyrosine Kinase/Adaptors
Syk-IN-3 是一种 Syk 抑制剂,具有潜在的抗炎和抗癌活性,可用于研究免疫失调。
T4348 Syk Inhibitor II

5-HT Receptor; Syk Angiogenesis; GPCR/G Protein; Neuroscience; Tyrosine Kinase/Adaptors
Syk Inhibitor II 是一种可渗透细胞、具有 ATP 竞争性的嘧啶-甲酰胺化合物,可选择性且可逆地抑制 Syk,IC50为 41 nM。
T9543 Syk Inhibitor II hydrochloride

Others Others
Syk Inhibitor II hydrochloride 信号传导的影响在狼疮中可能很突出。
T24843 Syk-IN-1

SykIN11,Syk-IN-11,Syk IN 11,Syk inhibitor-11,Syk inhibitor 11,Syk-inhibitor-11

Syk-IN-11 is a selective Syk inhibitor.
T37077 Syk-IN-4

Syk-IN-4 is a potent, selective, and orally bioavailable inhibitor of SYK, demonstrating an IC50 of 0.31 nM. It targets SYK, which has been identified as a potential therapeutic target for autoimmunity and hematological cancers[1].
T40976 Syk Kinase Peptide Substrate

Syk Kinase Peptide Substrate is a Syk kinase peptide substrate.
T70931 SYK-IN-II

SYK-IN-II is an inhibitor of the spleen tyrosine kinase (STK).
T4263 BAY 61-3606

2-[[7-(3,4-二甲氧基苯基)咪唑并[1,2-C]嘧啶-5-基]氨基]-3-吡啶甲酰胺,Syk inhibitor IV

Apoptosis; Syk Angiogenesis; Apoptosis; Tyrosine Kinase/Adaptors
BAY 61-3606 (Syk inhibitor IV) 是一种具有口服活性的,ATP 竞争性的可逆选择性Syk 抑制剂。它作用于乳腺癌细胞,通过下调 Mcl-1 促进 TRAIL 诱导的细胞凋亡。它降低神经母细胞瘤细胞中的 ERK1/2 和 Akt 磷酸化,也降低 K-rn 细胞裂解物中 Syk 磷酸化。
T79443 Syk-IN-8

Syk Angiogenesis; Tyrosine Kinase/Adaptors
Syk-IN-8(compound 19q)是一款Syk抑制剂,有效抗血液肿瘤细胞增殖。该化合物能够阻断PLCγ2的磷酸化过程,常用于血癌的科学研究。
T70930 GSK SYK inhibitor

The immunoregulator spleen tyrosine kinase (SYK) is upregulated in cutaneous lupus erythematosus (CLE). This double-blind, multicentre, Phase Ib study evaluated the safety, tolerability, pharmacokinetics, pharmacodynamics and clinical efficacy of the selective SYK inhibitor GSK2646264 in active CLE lesions
T28281 OXSI-2

OXSI 2,Syk Inhibitor

Syk Angiogenesis; Tyrosine Kinase/Adaptors
OXSI-2 (Syk Inhibitor) 是 Syk 的抑制剂,EC50 为 313 nM,IC50 为 14 nM。 OXSI-2 完全抑制适配器蛋白 LAT Y191 磷酸化和 Syk 介导的血小板聚集。
T78943 Syk-IN-7

Syk Angiogenesis; Tyrosine Kinase/Adaptors
Syk-IN-7(化合物17)是一类特定的酪氨酸激酶(SYK)抑制剂。
T63086 SYK/JAK-IN-1

SYK/JAK-IN-1 是一种 SYK/JAK 双重抑制剂,对 SYK 和 JAK2 的 IC50 值均小于 5 nM。
T62691 Syk Inhibitor II dihydrochloride dihydrate

Syk Inhibitor II dihydrochloride dihydrate 是一种高度选择性的、有效的、ATP 竞争性 Syk 抑制剂 (IC50: 41 nM)。Syk Inhibitor II dihydrochloride dihydrate 抑制 RBL 细胞释放 5-HT (IC50: 460 nM),对其他激酶的作用较弱。Syk Inhibitor II dihydrochloride dihydrate 表现出抗过敏作用。
T76083 Syk Kinase Peptide Substrate, Biotin labeled

SykKinase Peptide Substrate, Biotin labeled 是生物素标记的、Syk 激酶多肽底物。
T16776 RO9021

Syk Angiogenesis; Tyrosine Kinase/Adaptors
RO9021 是口服具有活力的,ATP 竞争性的 SYK 抑制剂,其 IC50=5.6 nM。
T39437 Cevidoplenib dimesylate

Syk Angiogenesis; Tyrosine Kinase/Adaptors
Cevidoplenib dimesylate 是一种脾酪氨酸激酶 (Syk) 抑制剂,具有抗炎和免疫调节特性。
T6594 MNS

Syk; Src; p97 Angiogenesis; Tyrosine Kinase/Adaptors; Ubiquitination
MNS 是一种酪氨酸激酶抑制剂和广谱抗血小板药物,是一种 β-硝基苯乙烯衍生物。它完全抑制 U46619 (IC50:2.1 μM)、ADP (IC50:4.1 μM)、花生四烯酸 (IC50:5.8 μM)、胶原 (IC50:7.0 μM)和凝血酶 (IC50:12.7 μM)诱导的血小板聚集,并抑制 Src (IC50:27.3 μM)、Syk (IC50:2.8 μM) 和 FAK (IC50:97.6 μM)。
T11824LL Lanraplenib

GS-9876

Syk Angiogenesis; Tyrosine Kinase/Adaptors
Lanraplenib (GS-9876) 是高效的、选择性的、口服具有活力的 SYK 抑制剂 (IC50=9.5 nM) ,能够用于炎症性疾病的研究。它通过糖蛋白 VI (GPVI) 受体抑制血小板中的 SYK 活性,而不会延长猴子或人类的出血时间 (BT)。
T6101 Entospletinib

GS-9973

Syk Angiogenesis; Tyrosine Kinase/Adaptors
Entospletinib (GS-9973) 是选择性的Syk 抑制剂,其IC50=7.7 nM。
T14331 Gusacitinib

ASN-002

JAK; Syk Angiogenesis; Chromatin/Epigenetic; JAK/STAT signaling; Stem Cells; Tyrosine Kinase/Adaptors
Gusacitinib (ASN-002) 是一种有效的 SYK 激酶和JAK 激酶的双抑制剂,IC50值为 5 到 46 nM 之间,具有抗癌活性。
T6115 Fostamatinib

R788,福他替尼

FLT; Syk; Monoamine Transporter; Adenosine Receptor Angiogenesis; GPCR/G Protein; Membrane transporter/Ion channel; Neuroscience; Tyrosine Kinase/Adaptors
Fostamatinib (R788) 是一种口服具有活力的 R406 前药。其中R406 是具有口服活性的,有效的,ATP 竞争性的Syk/FLT3抑制剂(Ki:30 nM,IC50:41 nM),也能够抑制 Lyn (IC50:63 nM) 和 Lck (IC50:37 nM)。
T3185 R112

(E)-Elafibranor

Syk Angiogenesis; Tyrosine Kinase/Adaptors
R112 ((E)-Elafibranor) 是ATP 竞争性的 Syk 激酶抑制剂,它能够抑制Syk 激酶活性,Ki=6 nM,IC50=226 nM。
T6957 PRT-060318

P142-76,PRT318,PRT-060318 2HCl

Syk Angiogenesis; Tyrosine Kinase/Adaptors
PRT-060318 (P142-76) 是一种新颖的、选择性的酪氨酸激酶 (Syk) 抑制剂,其IC50=4 nM。
T2487 Cerdulatinib

PRT2070,赛度替尼,PRT062070

Tyrosine Kinases; JAK; Syk Angiogenesis; Chromatin/Epigenetic; JAK/STAT signaling; Stem Cells; Tyrosine Kinase/Adaptors
Cerdulatinib (PRT2070) 是一种选择性 Tyk2抑制剂,IC50为 0.5 nM。它是 JAK 和 SYK 的双抑制剂,抑制JAK1、2、3 和SYK 的IC50分别为12、6、8 和 32。
T6174 R406

R-406 besylate

Apoptosis; FLT; Syk Angiogenesis; Apoptosis; Tyrosine Kinase/Adaptors
R406 (R-406 besylate) 是一种具有口服活性的 ATP 竞争性 Syk/FLT3抑制剂,Ki 为 30 nM。它有效抑制 Syk 激酶活性,IC50为 41 nM。它还抑制 Lyn 和 Lck,IC50值分别为 63 nM 和 37 nM。它可减轻免疫复合物介导的炎症。
T2467 R406 free base

R406 (free base)

Apoptosis; FLT; Syk Angiogenesis; Apoptosis; Tyrosine Kinase/Adaptors
R406 free base (R406(free base)) 是一种具有口服活性的,ATP 竞争性的Syk/FLT3抑制剂,Ki 为 30 nM。它有效抑制 Syk 激酶活性,IC50为 41 nM,可减轻免疫复合物介导的炎症。它还抑制 Lyn 和 Lck,IC50分别为 63 nM 和 37 nM。
T70929 Naldemedine tosylate

S-297995 tosylate

Naldemedine tosylate (S-297995)为具口服活性的μ-阿片受体拮抗剂(PAMORA)。其对重组人源μ-、δ-及κ-阿片受体展现出高亲和力(Ki分别为0.34,0.43,0.94 nM)及强拮抗效果(IC50分别为25.57,7.09,16.1 nM)。适用于研究由阿片类物质引起的便秘(OIC)。Naldemedine tosylate也被预测可能与SARS-CoV2 3CLpro结合。
T4209 TAK-659 hydrochloride

TAK-659

VEGFR; FLT; Tyrosine Kinases; JAK; Syk Angiogenesis; Chromatin/Epigenetic; JAK/STAT signaling; Stem Cells; Tyrosine Kinase/Adaptors
TAK-659 hydrochloride (TAK-659) 是可逆的、高效的、选择性的、口服有效的 SYK/FLT3 双抑制剂,对 SYK 和 FLT3 作用的IC50值分别为 3.2 nM、4.6 nM。它能诱导肿瘤细胞死亡,却不作用于非肿瘤细胞,对慢性淋巴细胞白血病具有潜在的研究价值。
T6776 BAY 61-3606 dihydrochloride

BAY 61-3606,BAY-61-3606 dihydrochloride

Apoptosis; Syk Angiogenesis; Apoptosis; Tyrosine Kinase/Adaptors
BAY 61-3606 dihydrochloride (BAY 61-3606) 是一种口服有效的,ATP 竞争性的,可逆的选择性Syk 抑制剂。它降低神经母细胞瘤细胞中的 ERK1/2 和 Akt 磷酸化,也降低 K-rn 细胞裂解物中 Syk 磷酸化。它作用于乳腺癌细胞,通过下调 Mcl-1 促进 TRAIL 诱导的细胞凋亡。
T0948 Adrenalone hydrochloride

Adrenalone HCl,肾上腺酮盐酸盐,盐酸肾上腺酮

Adrenergic Receptor GPCR/G Protein; Neuroscience
Adrenalone hydrochloride (Adrenalone HCl) 是一种多巴胺β氧化酶 (dopamine β oxidase) 抑制剂,结构与去甲肾上腺素转运蛋白 (NET) 配体相似,IC50=36.9 μM。它是一种肾上腺素能 (adrenergic) 激动剂,用作局部血管收缩剂和止血剂。
T2696 PRT062607 hydrochloride

PRT062607 (P505-15, BIIB057) HCl,P505-15 Hydrochloride

MLK; Syk; Src Angiogenesis; MAPK; Tyrosine Kinase/Adaptors
PRT062607 hydrochloride (P505-15 Hydrochloride) 是纯化的 Syk 抑制剂,IC50=1-2 nM。
T6104 Cerdulatinib hydrochloride

Cerdulatinib,PRT2070,PRT062070 hydrochloride,PRT062070,PRT2070 hydrochloride

MLK; c-Fms; Tyrosine Kinases; Hippo pathway; JAK; Syk Angiogenesis; Chromatin/Epigenetic; JAK/STAT signaling; MAPK; Stem Cells; Tyrosine Kinase/Adaptors
Cerdulatinib hydrochloride (PRT2070 hydrochloride) 是一种选择性可逆,具有口服活性、 ATP 竞争性的 SYK 和 JAK 的双重抑制剂,抑制 JAK1、2、3、SYK 和 Tyk2的 IC50值分别为12、6、8、32 和 0.5 nM。它可用于研究自身免疫性疾病和B 细胞恶性肿瘤。
T2605 Fostamatinib Disodium

Tamatinib Fosdium,福他替尼二钠盐,R788(Disodium),R788 Disodium,R788 (Fostamatinib) Disodium

FLT; Syk Angiogenesis; Tyrosine Kinase/Adaptors
Fostamatinib Disodium (R788 Disodium) 是一种口服具有活力的 R406 前药。其中R406 是具有口服活性的,有效的,ATP 竞争性的Syk/FLT3抑制剂(Ki:30 nM,IC50:41 nM),也能够抑制 Lyn (IC50:63 nM) 和 Lck (IC50:37 nM)。
T22430 SRX3207

Others; PI3K; Syk Angiogenesis; Others; PI3K/Akt/mTOR signaling; Tyrosine Kinase/Adaptors
SRX3207 是 Syk 和 PI3K 的抑制剂,可缓解肿瘤免疫抑制。
T32088 Sovleplenib

HMPL 523,HMPL523,HMPL-523

Syk Angiogenesis; Tyrosine Kinase/Adaptors
Sovleplenib (HMPL523) 是一种可口服且具有选择性和高效性的脾酪氨酸激酶 SYK 抑制剂,IC50 为 25 nM。Sovleplenib 具有抗肿瘤活性,可用于免疫性血小板减少症(ITP)的研究。
T9789 Cevidoplenib dimesylate hydrochloride

Syk Angiogenesis; Tyrosine Kinase/Adaptors
Cevidoplenib dimesylate hydrochloride 是一种脾酪氨酸激酶 (Syk) 抑制剂,具有潜在的免疫调节和抗炎特性。
T2045 JANEX-1

Jak3 inhibitor I,WHI-P131

JAK Angiogenesis; Chromatin/Epigenetic; JAK/STAT signaling; Stem Cells
JANEX-1 (Jak3 inhibitor I) 是一种特异性JAK3抑制剂,Ki 和IC50分别为 2.3 和 78 μM。
T2600 AG490

Zinc02557947,Tyrphostin AG 490,AG 490,AG-490,Tyrphostin B42

EGFR; JAK; STAT; Autophagy Angiogenesis; Autophagy; Chromatin/Epigenetic; JAK/STAT signaling; Stem Cells; Tyrosine Kinase/Adaptors
AG490 (Tyrphostin B42) 是一种 EGFR 抑制剂 ,IC50为 0.1 μM。它对 EGFR 的选择性比 ErbB2 高 135 倍,还抑制 JAK2。
T6277 Doramapimod

BIRB 796,达马莫德,度马莫德

Raf; p38 MAPK; Autophagy Autophagy; MAPK
Doramapimod (BIRB 796) 是一种具有口服活性的p38 MAPK 抑制剂,Kd 值为0.1nM。它也抑制B-Raf 和 Abl,IC50分别为 83 nM 和 14.6 μM。
T32613 LCB 03-0110 dihydrochloride

Src Angiogenesis; Tyrosine Kinase/Adaptors
LCB 03-0110 Dihydrochloride 是BTK 和SYK 家族以及DDR2家族中c-Src 激酶(IC50=1.3 nM)和酪氨酸激酶的有效抑制剂。在体外抑制LPS 诱导的巨噬细胞活化和TGF-β1诱导的成纤维细胞活化,抑制巨噬细胞和成纤维细胞的活化,并抑制伤口愈合模型中的瘢痕形成。
T5524 Aurora kinase inhibitor-3

Aurora Kinase Inhibitor III

Aurora Kinase Cell Cycle/Checkpoint; Chromatin/Epigenetic
Aurora kinase inhibitor-3 (Aurora Kinase Inhibitor III) 是一种有效的,选择性 Aurora A 激酶抑制剂,IC50为 42 nM。
T9428 HM43239

FLT Angiogenesis; Tyrosine Kinase/Adaptors
HM43239 是一种具有口服活性和选择性 FLT3抑制剂,IC50值为 1.1 nM (FLT3 野生型)、1.8 nM (FLT3 ITD 突变型) 和 1.0 nM (FLT3 D835Y 突变型)。HM43239 作为可逆的 I 型抑制剂直接抑制 FLT3 的激酶活性,并调节 p-STAT5, p-ERK SYK, JAK1/2 和 TAK1。HM43239 抑制白血病细胞的增殖并诱导其凋亡 (apoptosis)。
T3211 Midostaurin

米哚妥林,N-Benzoylstaurosporine,PKC412,CGP41231,CGP 41251,苯甲酰基十字孢碱

Others; PKC Chromatin/Epigenetic; Cytoskeletal Signaling; Others
Midostaurin (PKC412) 是一种多靶点蛋白激酶抑制剂,有抗肿瘤活性,对 PKCα/β/γ、Syk、Flk-1、Akt、PKA、c-Kit、c-Fgr、c-Src、FLT3、PDFRβ和VEGFR1/2的IC50值范围为 22 到500 nM 之间。
T24584 P505-15 Acetate

PRT 062607 Acetate,P505 15 Acetate,PRT-062607 Acetate,PRT062607 Acetate,P50515 Acetate

Tyrosinase Proteases/Proteasome
P505-15 Acetate 是脾脏酪氨酸激酶的选择性抑制剂,通过抑制白细胞免疫功能和炎症起作用,导致关节炎评分降低和组织学损伤减轻。
T11824 Lanraplenib succinate

GS-9876 succinate

Syk Angiogenesis; Tyrosine Kinase/Adaptors
Lanraplenib succinate inhibits SYK activity in platelets via the glycoprotein VI (GPVI) receptor without prolonging bleeding time (BT) in monkeys or humans. Lanraplenib succinate is a highly selective and orally active SYK inhibitor (IC50=9.5 nM) in development for the treatment of inflammatory diseases.
T11824L Lanraplenib monosuccinate

GS-9876 monosuccinate

Syk Angiogenesis; Tyrosine Kinase/Adaptors
Lanraplenib monosuccinate inhibits SYK activity in platelets via the glycoprotein VI (GPVI) receptor without prolonging bleeding time (BT) in monkeys or humans. Lanraplenib monosuccinate is a highly selective and orally active SYK inhibitor (IC50=9.5 nM) in development for the treatment of inflammatory diseases.
T16995 TAS05567

FLT; c-RET; JAK; Syk Angiogenesis; Apoptosis; Chromatin/Epigenetic; JAK/STAT signaling; Stem Cells; Tyrosine Kinase/Adaptors
TAS05567 is a potent, highly selective, and ATP-competitive Syk inhibitor (IC50: 0.37 nM). TAS05567 only shows >70% inhibition of Syk and 4 other kinases (FLT3, JAK2, KDR, and RET with IC50s of 10 nM, 4.8 nM, 600 nM, and 29 nM, respectively) in a panel of 192 kinases.
T21062 TAK-659

TAK 659,TAK659

TAK-659 is a spleen tyrosine kinase (SYK) inhibitor.

化合物

Syk Inhibitor II dihydrochloride
Cat.No: T4391
Synonym: Syk Inhibitor II (hydrochloride)
Target: Others, Tyrosine Kinases, Syk, PKC, BTK
Syk-IN-3
Cat.No: T13045
Synonym:
Target: Syk
Syk Inhibitor II
Cat.No: T4348
Synonym:
Target: 5-HT Receptor, Syk
Syk Inhibitor II hydrochloride
Cat.No: T9543
Synonym:
Target: Others
Syk-IN-1
Cat.No: T24843
Synonym: SykIN11,Syk-IN-11,Syk IN 11,Syk inhibitor-11,Syk inhibitor 11,Syk-inhibitor-11
Target:
Syk-IN-4
Cat.No: T37077
Synonym:
Target:
Syk Kinase Peptide Substrate
Cat.No: T40976
Synonym:
Target:
SYK-IN-II
Cat.No: T70931
Synonym:
Target:
BAY 61-3606
Cat.No: T4263
Synonym: 2-[[7-(3,4-二甲氧基苯基)咪唑并[1,2-C]嘧啶-5-基]氨基]-3-吡啶甲酰胺,Syk inhibitor IV
Target: Apoptosis, Syk
Syk-IN-8
Cat.No: T79443
Synonym:
Target: Syk
GSK SYK inhibitor
Cat.No: T70930
Synonym:
Target:
OXSI-2
Cat.No: T28281
Synonym: OXSI 2,Syk Inhibitor
Target: Syk
Syk-IN-7
Cat.No: T78943
Synonym:
Target: Syk
SYK/JAK-IN-1
Cat.No: T63086
Synonym:
Target:
Syk Inhibitor II dihydrochloride dihydrate
Cat.No: T62691
Synonym:
Target:
Syk Kinase Peptide Substrate, Biotin labeled
Cat.No: T76083
Synonym:
Target:
RO9021
Cat.No: T16776
Synonym:
Target: Syk
Cevidoplenib dimesylate
Cat.No: T39437
Synonym:
Target: Syk
MNS
Cat.No: T6594
Synonym:
Target: Syk, Src, p97
Lanraplenib
Cat.No: T11824LL
Synonym: GS-9876
Target: Syk
Entospletinib
Cat.No: T6101
Synonym: GS-9973
Target: Syk
Gusacitinib
Cat.No: T14331
Synonym: ASN-002
Target: JAK, Syk
Fostamatinib
Cat.No: T6115
Synonym: R788,福他替尼
Target: FLT, Syk, Monoamine Transporter, Adenosine Receptor
R112
Cat.No: T3185
Synonym: (E)-Elafibranor
Target: Syk
PRT-060318
Cat.No: T6957
Synonym: P142-76,PRT318,PRT-060318 2HCl
Target: Syk
Cerdulatinib
Cat.No: T2487
Synonym: PRT2070,赛度替尼,PRT062070
Target: Tyrosine Kinases, JAK, Syk
R406
Cat.No: T6174
Synonym: R-406 besylate
Target: Apoptosis, FLT, Syk
R406 free base
Cat.No: T2467
Synonym: R406 (free base)
Target: Apoptosis, FLT, Syk
Naldemedine tosylate
Cat.No: T70929
Synonym: S-297995 tosylate
Target:
TAK-659 hydrochloride
Cat.No: T4209
Synonym: TAK-659
Target: VEGFR, FLT, Tyrosine Kinases, JAK, Syk
BAY 61-3606 dihydrochloride
Cat.No: T6776
Synonym: BAY 61-3606,BAY-61-3606 dihydrochloride
Target: Apoptosis, Syk
Adrenalone hydrochloride
Cat.No: T0948
Synonym: Adrenalone HCl,肾上腺酮盐酸盐,盐酸肾上腺酮
Target: Adrenergic Receptor
PRT062607 hydrochloride
Cat.No: T2696
Synonym: PRT062607 (P505-15, BIIB057) HCl,P505-15 Hydrochloride
Target: MLK, Syk, Src
Cerdulatinib hydrochloride
Cat.No: T6104
Synonym: Cerdulatinib,PRT2070,PRT062070 hydrochloride,PRT062070,PRT2070 hydrochloride
Target: MLK, c-Fms, Tyrosine Kinases, Hippo pathway, JAK, Syk
Fostamatinib Disodium
Cat.No: T2605
Synonym: Tamatinib Fosdium,福他替尼二钠盐,R788(Disodium),R788 Disodium,R788 (Fostamatinib) Disodium
Target: FLT, Syk
SRX3207
Cat.No: T22430
Synonym:
Target: Others, PI3K, Syk
Sovleplenib
Cat.No: T32088
Synonym: HMPL 523,HMPL523,HMPL-523
Target: Syk
Cevidoplenib dimesylate hydrochloride
Cat.No: T9789
Synonym:
Target: Syk
JANEX-1
Cat.No: T2045
Synonym: Jak3 inhibitor I,WHI-P131
Target: JAK
AG490
Cat.No: T2600
Synonym: Zinc02557947,Tyrphostin AG 490,AG 490,AG-490,Tyrphostin B42
Target: EGFR, JAK, STAT, Autophagy
Doramapimod
Cat.No: T6277
Synonym: BIRB 796,达马莫德,度马莫德
Target: Raf, p38 MAPK, Autophagy
LCB 03-0110 dihydrochloride
Cat.No: T32613
Synonym:
Target: Src
Aurora kinase inhibitor-3
Cat.No: T5524
Synonym: Aurora Kinase Inhibitor III
Target: Aurora Kinase
HM43239
Cat.No: T9428
Synonym:
Target: FLT
Midostaurin
Cat.No: T3211
Synonym: 米哚妥林,N-Benzoylstaurosporine,PKC412,CGP41231,CGP 41251,苯甲酰基十字孢碱
Target: Others, PKC
P505-15 Acetate
Cat.No: T24584
Synonym: PRT 062607 Acetate,P505 15 Acetate,PRT-062607 Acetate,PRT062607 Acetate,P50515 Acetate
Target: Tyrosinase
Lanraplenib succinate
Cat.No: T11824
Synonym: GS-9876 succinate
Target: Syk
Lanraplenib monosuccinate
Cat.No: T11824L
Synonym: GS-9876 monosuccinate
Target: Syk
TAS05567
Cat.No: T16995
Synonym:
Target: FLT, c-RET, JAK, Syk
TAK-659
Cat.No: T21062
Synonym: TAK 659,TAK659
Target:
Cat. No. Product Name Target Signaling Pathways
TN1644 Flavanomarein

Others Others
Flavanomarein 是Coreopsis tinctoria Nutt 的主要黄酮类化合物,对糖尿病性肾病具有保护作用。它具有很好的抗氧化,降糖,降压和降血脂作用。
T0610 Piceatannol

白皮杉醇,trans-Piceatannol,Astringenin

Apoptosis; Serine/threonin kinase; PKA; Syk; PKC; Autophagy Angiogenesis; Apoptosis; Autophagy; Cell Cycle/Checkpoint; Chromatin/Epigenetic; Cytoskeletal Signaling; Metabolism; Tyrosine Kinase/Adaptors
Piceatannol (Astringenin) 是一种Syk 抑制剂,可降低由 TNF 诱导的 iNOS 表达,可研究急性肺损伤。它是存在于各种水果和蔬菜中天然存在的多酚二苯乙烯,可诱导细胞自噬和凋亡,具有抗癌和抗炎特性。
TN7075 Linocinnamarin

3-[4-(beta-D-Glucopyranosyloxy)phenyl]acrylic acid methyl ester

Phospholipase; Syk Angiogenesis; Metabolism; Tyrosine Kinase/Adaptors
Linocinnamarin (3-[4-(beta-D-Glucopyranosyloxy)phenyl]acrylic acid methyl ester) 是从 Fragaria ananassa Duch 中分离出来的。 它对抗原刺激脱粒的抑制主要是由于 Syk/磷脂酶 Cgamma (PLCgamma) 途径的失活。
T4S0498 Glaucocalyxin A

蓝萼甲素,Wangzaozin B,Leukamenin F

Apoptosis; Akt; Caspase; PI3K Apoptosis; Cytoskeletal Signaling; PI3K/Akt/mTOR signaling; Proteases/Proteasome
Glaucocalyxin A (Leukamenin F) 是来自日本黑纹病菌的一种对映型月桂基二萜,具有抗肿瘤作用。它通过调节PI3K/Akt 信号通路抑制 GLI1 的核易位,诱导骨肉瘤凋亡。
TN6667 Spinacetin

Spinacetin has anti-inflammatory effects, it weakly inhibited nitric oxide production and reduced prostaglandin E2 levels to different extents. It shows the activities in preventing inflammatory processes, which might be at least partially attributed to t

天然产物

Flavanomarein
Cat.No: TN1644
Synonym:
Target: Others
Piceatannol
Cat.No: T0610
Synonym: 白皮杉醇,trans-Piceatannol,Astringenin
Target: Apoptosis, Serine/threonin kinase, PKA, Syk, PKC, Autophagy
Linocinnamarin
Cat.No: TN7075
Synonym: 3-[4-(beta-D-Glucopyranosyloxy)phenyl]acrylic acid methyl ester
Target: Phospholipase, Syk
Glaucocalyxin A
Cat.No: T4S0498
Synonym: 蓝萼甲素,Wangzaozin B,Leukamenin F
Target: Apoptosis, Akt, Caspase, PI3K
Spinacetin
Cat.No: TN6667
Synonym:
Target:
共67条,每页50条 1 2
TargetMol Loading
联系我们
400-820-0310

上海市静安区江场三路238号8楼